Clinical Trials in Baltimore

Showing 5601-5620 of 17,842 trials

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

NCT02561455

The purpose of the study was to provide access to continued treatment for those who participated in other Astellas sponsored ASP2215 trials that completed the primary analysis and, had the potential to continue to derive clinical benefit from the treatment with ASP2215, and who did not meet any of the study discontinuation criteria in the present study.

Advanced Solid TumorsAcute Myeloid Leukemia

Astellas Pharma Global Development, Inc.9 participantsStarted May 2016

Phoenix, Arizona, United States • Baltimore, Maryland, United States • New York, New York, United States +4 more locations

COMPLETEDPhase 1/2< 1 mile

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

NCT02614066

The primary objectives of this study are to determine the safety and efficacy of brexucabtagene autoleucel (KTE-X19) in adult participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL).

Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Kite, A Gilead Company125 participantsStarted Mar 2016

La Jolla, California, United States • Los Angeles, California, United States • Orange, California, United States +30 more locations

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

Find Trials by Condition in Baltimore

A Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell Carcinoma

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1

Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency

Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Zip-Stitch® in Minimally-Invasive Surgery (ZIMS) - Safety & Efficacy in Hysterectomy

Pediatric Cardiac Output Monitoring Observational Study

Pediatric Adenotonsillectomy Trial for Snoring

Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome

Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers